Can an inhaled protein save lungs in Alpha-1? new trial aims to find out
Disease control
Recruiting now
This study tests whether inhaling alpha-1 antitrypsin (AAT) daily can slow lung function loss in people with Alpha-1 deficiency and moderate-to-severe lung disease. 220 adults will receive either the drug or a placebo for two years, then all will receive the drug for two more yea…
Phase: PHASE3 • Sponsor: Kamada, Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:26 UTC